Welcome to our dedicated page for Healthwarehouse news (Ticker: HEWA), a resource for investors and traders seeking the latest updates and insights on Healthwarehouse stock.
HealthWarehouse.com, Inc. (OTCQB: HEWA) is a healthcare e‑commerce and technology company that regularly publishes detailed financial and operational updates. As an NABP Approved Digital Pharmacy based in Florence, Kentucky, HealthWarehouse.com reports on its performance in selling and delivering prescription and over‑the‑counter medications to customers in all 50 states, serving both direct‑to‑consumer and partner services (B2B) channels.
On this page, readers can follow HEWA news that covers quarterly and annual results, trends in prescription and over‑the‑counter sales, and management’s commentary on business drivers. Company releases discuss net sales, gross profit, operating expenses, net income or loss, and non‑GAAP measures such as EBITDA and Adjusted EBITDA, along with explanations of how product mix and partner services margins affect these figures.
HealthWarehouse.com’s news flow often highlights the impact of GLP‑1 medications on its results, including brand and compounded GLP‑1 prescriptions fulfilled through its partner services and direct‑to‑consumer businesses. The company also reports on technology initiatives, such as new pharmacy software and a proprietary e‑commerce platform, and how these investments relate to patient experience, operational efficiency, and scalability.
Investors and observers can use this news feed to review management’s discussion of topics like cold‑chain shipping capabilities, changes in over‑the‑counter marketplace sales, and the evolution of its B2B partner services pipeline. For ongoing insight into HealthWarehouse.com’s operating trends, financial performance, and strategic focus areas, this HEWA news page aggregates the company’s latest publicly released updates.
Summary not available.
HealthWarehouse.com, Inc. (OTCQB:HEWA) reported a 12% increase in net sales for 2022, totaling $18,142,633 driven by significant growth in partner services revenue. However, the company experienced a net loss of $952,029, worsening from $572,502 in 2021. Despite this, HealthWarehouse.com achieved positive cash flow for the sixth consecutive year with an Adjusted EBITDA of $146,787. Direct-to-consumer sales declined by 3.5%, while partner services revenue nearly doubled. Operating expenses rose by 10.7% to $12,725,433, largely due to increased shipping and salaries. The company plans to launch a new e-commerce platform in 2023.
HealthWarehouse.com, Inc. (OTC:HEWA) reported net sales of $4,681,302 for Q3 2022, an 11% increase from Q3 2021, driven by growth in partner services. The company recorded a loss from operations of $225,614, yet reported positive cash flow with an Adjusted EBITDA of $47,673. Prescription sales increased by 6.4% to $3,873,323, and OTC sales surged 46.2% to $736,265. Despite higher gross profit, operating expenses rose by 11.2%, leading to net losses slightly widening compared to last year. Future plans include launching a proprietary e-commerce platform aimed at improving customer retention.
HealthWarehouse.com, Inc. (OTC:HEWA) reported a 6% revenue increase in Q2 2022, totaling $4,199,832, driven by growth in partner services. However, the company experienced operational losses of $293,524 for the quarter and $507,512 for the first half of the year. Prescription sales rose by 4.5%, while over-the-counter sales jumped by 18.1%. Despite the revenue growth, gross margins declined slightly, and operating expenses increased by nearly 10%. The company is planning to launch a new e-commerce platform in Q4 2022 and has been recognized as a Top Workplace in Greater Cincinnati.
HealthWarehouse.com (OTC:HEWA) reported a 13% increase in revenues, totaling
HealthWarehouse.com (OTCQB: HEWA) reported 2021 net sales of $16,143,906, a 6% decrease from 2020, despite a 2% increase in prescription sales driven by partner services revenue.
The company posted a loss from operations of $572,502, but achieved positive cash flow for the fifth consecutive year with an Adjusted EBITDA of $459,208. Over-the-counter sales fell by 36.7%, influenced by reduced consumer demand post-COVID-19 peaks.
Looking ahead, the company plans to launch a new e-commerce platform in early 2022 to enhance customer experience and services.
HealthWarehouse.com (OTCQB: HEWA) reported a net sales increase of 5% to $4,212,127 for Q3 2021, with prescription sales up 13%. The company posted a loss from operations of $181,031 but achieved positive cash flow with an Adjusted EBITDA of $89,797. The decline in over-the-counter sales by 27% was attributed to decreased website traffic compared to pandemic highs in 2020. Despite the challenges, HealthWarehouse.com plans to expand B2B offerings and invest in technology to enhance customer experience.
HealthWarehouse.com, Inc. (OTC: HEWA) reported a net loss of $181,811 for Q2 2021, a considerable drop from the prior year. Despite a 13% decline in net sales to $3,954,892, the company achieved a positive Adjusted EBITDA of $87,636. Prescription sales rose slightly, while over-the-counter sales fell by 50.5%. Operating expenses reduced by 5.2%. The company transitioned to the OTCQB market to enhance its investment appeal. CEO Joseph Peters highlighted a focus on technology investments and an anticipated sales uptick in the latter half of 2021.
HealthWarehouse.com, Inc. (OTCQB: HEWA) reported a net loss of $131,025 for Q1 2021, an increase from a loss of $68,428 in Q1 2020. Despite this, the company achieved a positive Adjusted EBITDA of $124,114. Net sales declined by 16% to $3,818,285, driven by decreased consumer demand and lower website traffic. Prescription sales fell by 9.9%, and over-the-counter sales decreased by 36.8%. Operating expenses decreased by 5.2%. Gross profit was $2,651,875, reflecting a 7.8% decrease, but gross margin improved to 69.5% through strategic purchasing efforts.
HealthWarehouse.com, Inc. (OTCQB:HEWA) has announced that its common stock will start trading on the OTCQB Market, enhancing investor visibility and potential liquidity. President Joseph Peters positioned this as a significant milestone, stating it could attract greater investor interest compared to the previous OTC Pink Sheets listing. The OTCQB requires companies to meet specific financial and reporting criteria, further strengthening its market position. HealthWarehouse.com offers affordable online pharmacy services nationwide, supporting its mission to deliver quality healthcare.